Verapamil reduces glucose and fatty acid metabolism of beating and nonbeating rat heart cells.
The effects of various dosages of verapamil on glucose or fatty acid utilization by beating or nonbeating rat heart myocytes in tissue culture were determined. Myocytes were incubated with verapamil and either D-6-14C glucose or 1-14C palmitic acid as substrate. After incubation the subsequently generated 14CO2 was captured with hyamine hydroxide and the equivalent oxygen values were calculated. Low doses of verapamil (50 ng/ml) treatment produced a 52% reduction in myocyte glucose utilization and a 16% reduction in fatty acid utilization that appeared to be independent of its effect on myocyte contractile rate since these effects were evident in both beating and nonbeating myocytes. In addition, verapamil treatment caused differences in the myocyte handling of substrate. Verapamil (50 ng/ml) lowered cellular accumulation of glucose by 21% compared to controls. Contrary to glucose, myocyte concentrations of palmitic acid were significantly increased by 117% relative to controls in verapamil treated cultures. These results suggest that verapamil may have a direct effect on basal heart cell metabolism in a way that is unrelated to myocyte contractile activity. In addition, verapamil may interfere with glucose membrane transport.
D000818:Animals; D046508:Culture Techniques; D004305:Dose-Response Relationship, Drug; D005227:Fatty Acids / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D019308:Palmitic Acid; D010169:Palmitic Acids / Q000378:metabolism; D051381:Rats; D014700:Verapamil / Q000494:pharmacology*
D005227:Fatty Acids; D010169:Palmitic Acids; D019308:Palmitic Acid; D014700:Verapamil; D005947:Glucose